Drug Profile
Naltrexone transmucosal - Bionex Pharmaceuticals
Latest Information Update: 28 Oct 2021
Price :
$50
*
At a glance
- Originator Bionex Pharmaceuticals
- Class Anti-inflammatories; Antineoplastics; Antivirals; Cyclopropanes; Drug withdrawal therapies; Ethers; Eye disorder therapies; Irritable bowel syndrome therapies; Ketones; Morphinans; Non-opioid analgesics; Small molecules
- Mechanism of Action Opioid receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Alcoholism
Most Recent Events
- 28 Nov 2018 No recent reports of development identified for research development in Alcoholism in USA (Transmucosal, Film)
- 16 Nov 2016 Chemical structure information added
- 14 Nov 2016 Early research development is ongoing for Alcoholism in USA (Bionex Pharmaceuticals website, November 2016)